Intermediate-acting nondepolarizing neuromuscular blocking agents and risk of postoperative 30-day morbidity and mortality, and long-term survival

Anesthesia and Analgesia

Volumn 124, Issue 5, 2017, Pages 1476-1483

  Bronsert, Michael R ^a,b   Henderson, William G ^a,b   Monk, Terri G ^c,d   Richman, Joshua S ^e   Nguyen, Jennifer D ^f   Sum Ping, John T ^g   Mangione, Michael P ^h   Higley, Binh ^f   Hammermeister, Karl E ^a,b,i  

^a Adult and Child Center for Health Outcomes Research and Delivery Science   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c University of Missouri   (United States)

^d DURHAM VA MEDICAL CENTER   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f BAYLOR COLLEGE OF MEDICINE   (United States)

^g UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^h UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISATRACURIUM; NEOSTIGMINE; ROCURONIUM; VECURONIUM; CHOLINESTERASE INHIBITOR; NEUROMUSCULAR BLOCKING AGENT;

ACUTE KIDNEY FAILURE; ADULT; ADVERSE OUTCOME; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; GENERAL ANESTHESIA; HEART ARREST; HEART INFARCTION; HUMAN; INTRAOPERATIVE PERIOD; KIDNEY FAILURE; LONG TERM SURVIVAL; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MORBIDITY; NEUROMUSCULAR BLOCKING; OBSERVATIONAL STUDY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY ANALYSIS; SEPSIS; SURGICAL INFECTION; SURGICAL MORTALITY; SURGICAL RISK; URINARY TRACT INFECTION; VENTILATOR WEANING; WOUND DEHISCENCE; ADVERSE EFFECTS; AGED; ANESTHETIC RECOVERY; ANTAGONISTS AND INHIBITORS; CHEMICALLY INDUCED; FEMALE; MALE; MIDDLE AGED; MORTALITY; POSTOPERATIVE COMPLICATIONS; RESPIRATORY TRACT DISEASES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

ADULT; AGED; ANESTHESIA RECOVERY PERIOD; CHOLINESTERASE INHIBITORS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOSTIGMINE; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR NONDEPOLARIZING AGENTS; POSTOPERATIVE COMPLICATIONS; RESPIRATORY TRACT DISEASES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 85014033571     PISSN: 00032999     EISSN: 15267598     Source Type: Journal    
DOI: 10.1213/ANE.0000000000001848     Document Type: Article

References (34)

1. Plaud B, Debaene B, Donati F, Marty J. Residual paralysis after emergence from anesthesia. Anesthesiology. 2010;112:1013-1022.
2. Donati F. Residual paralysis: A real problem or did we invent a new disease?. Can J Anaesth. 2013;60:714-729.
3. Naguib M, Kopman AF, Ensor JE. Neuromuscular monitoring and postoperative residual curarization: A meta-analysis. Br J Anasesth. 2007;98:302-316.
4. Murphy GS, Szokol JW, Marymont JH, Greenberg SB, Avram MJ, Vender JS. Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit. Anesth Analg. 2008;107:130-137.
5. Murphy GS, Brull SJ. Residual neuromuscular block: Lessons unlearned. Part I: Definitions, incidence, and adverse physiologic effects of residual neuromuscular block. Anesth Analg. 2010;111:120-128.
6. Grosse-Sundrup M, Henneman JP, Sandberg WS, et al. Intermediate acting non-depolarizing neuromuscular blocking agents and risk of postoperative respiratory complications: Prospective propensity score matched cohort study. BMJ. 2012;345:e6329.
7. Khuri SF, Daley J, Henderson W, et al. The National Veterans Administration Surgical Risk Study: Risk adjustment for the comparative assessment of the quality of surgical care. J Am Coll Surg. 1995;180:519-531.
8. Daley J, Khuri SF, Henderson W, et al. Risk adjustment of the postoperative morbidity rate for the comparative assessment of the quality of surgical care: Results of the National Veterans Affairs Surgical Risk Study. J Am Coll Surg. 1997;185:328-340.
9. Daley J, Forbes MG, Young GJ, et al. Validating risk-adjusted surgical outcomes: Site visit assessment of process and structure. National VA Surgical Risk Study. J Am Coll Surg. 1997;185:341-351.
10. Khuri SF, Daley J, Henderson W, et al. Risk adjustment of the postoperative mortality rate for the comparative assessment of the quality of surgical care: Results of the National Veterans Affairs Surgical Risk Study. J Am Coll Surg. 1997;185:315-327.
11. Khuri SF, Daley J, Henderson W, et al. The Department of Veterans Affairs' NSQIP: The first national, validated, outcomebased, risk-adjusted, and peer-controlled program for the measurement and enhancement of the quality of surgical care. National VA Surgical Quality Improvement Program. Ann Surg. 1998;228:491-507.
12. Davis CL, Pierce JR, Henderson W, et al. Assessment of the reliability of data collected for the Department of Veterans Affairs national surgical quality improvement program. J Am Coll Surg. 2007;204:550-560.
13. Sohn MW, Arnold N, Maynard C, Hynes DM. Accuracy and completeness of mortality data in the Department of Veterans Affairs. Popul Health Metr. 2006;4:2.
14. Meguid RA, Bronsert MR, Juarez-Colunga E, Hammermeister KE, Henderson WG. Surgical Risk Preoperative Assessment System (SURPAS): I. Parsimonious, clinically meaningful groups of postoperative complications by factor analysis. Ann Surg. 2016;263:1042-1048.
15. Gibbs J, Cull W, Henderson W, Daley J, Hur K, Khuri SF. Preoperative serum albumin level as a predictor of operative mortality and morbidity: Results from the National VA Surgical Risk Study. Arch Surg. 1999;134:36-42.
16. Buck SF. A method of estimation of missing values in multivariate data suitable for use with an electronic computer. J Roy Stat Soc. 1960; 22: 302-307.
17. Austin PC. A comparison of 12 algorithms for matching on the propensity score. Stat Med. 2014;33:1057-1069.
18. Rosenbaum PR. Observational Studies. New York, NY: Springer-Verlag, 2002.
19. Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensityscore matched samples. Stat Med. 2009;28:3083-3107.
20. Cox DR. Regression models and life-tables. J Roy Stat Soc. 1972; 43: 187-220.
21. Bewick V, Cheek L, Ball J. Statistics review 12: Survival analysis. Crit Care. 2004;8:389-394.
22. Cohen ME, Dimick JB, Bilimoria KY, Ko CY, Richards K, Hall BL. Risk adjustment in the American College of Surgeons National Surgical Quality Improvement Program: A comparison of logistic versus hierarchical modeling. J Am Coll Surg. 2009;209:687-693.
23. Hannan EL, Wu C, DeLong ER, Raudenbush SW. Predicting risk-adjusted mortality for CABG surgery: Logistic versus hierarchical logistic models. Med Care. 2005;43:726-735.
24. Hsieh FY. Sample size tables for logistic regression. Stat Med. 1989;8:795-802.
25. Beemer GH, Rozental P. Postoperative neuromuscular function. Anaesth Intensive Care. 1986;14:41-45.
26. Pedersen T, Viby-Mogensen J, Bang U, Olsen NV, Jensen E, Engbaek J. Does perioperative tactile evaluation of the train-of-four response influence the frequency of postoperative residual neuromuscular blockade?. Anesthesiology. 1990;73:835-839.
27. Arbous MS, Meursing AE, Van Kleef JW, et al. Impact of anesthesia management characteristics on severe morbidity and mortality. Anesthesiology. 2005;102:257-268.
28. Song IA, Seo KS, Oh AY, et al. Timing of reversal with respect to three nerve stimulator end-points from cisatracurium-induced neuromuscular block. Anaesthesia. 2015;70:797-802.
29. Choi ES, Oh AT, Seo KS, et al. Optimum dose of neostigmine to reverse shallow neuromuscular blockade with rocuronium and cisatracurium. Anaesthesia. 2016;71:443-449.
30. Meyer MJ, Bateman BT, Kurth T, Eikermann M. Neostigmine reversal doesn't improve postoperative respiratory safety. BMJ. 2013;346:f1460.
31. McLean DJ, Diaz-Gil D, Farhan HN, Ladha KS, Kurth T, Eikermann M. Dose-dependent association between intermediate-acting neuromuscular-blocking agents and postoperative respiratory complications. Anesthesiology. 2015;122:1201-1213.
32. Bulka CM, Terekhov MA, Martin BJ, Dmochowski RR, Hayes RM, Ehrenfeld JM. Nondepolarizing neuromuscular blocking agents, reversal, and risk of postoperative pneumonia. Anesthesiology. 2016;125:647-655.
33. Murphy GS, Kopman AF. To reverse or not to reverse. The answer is clear. Anesthesiology. 2016;125:611-614.
34. Keating GM. Sugammadex: A review of neuromuscular blockade reversal. Drugs. 2016;76:1041-1052.